hepat
e
viru
hev
respons
larg
waterborn
epidem
hepat
endem
countri
emerg
zoonot
pathogen
worldwid
endem
region
genotyp
frequent
associ
fulmin
hepat
pregnant
women
zoonot
hev
chronic
case
hepat
sever
neurolog
disord
report
henc
import
character
interact
hev
host
investig
abil
nonstructur
polyprotein
encod
first
open
read
frame
hev
modul
host
earli
antivir
respons
particular
type
interferon
ifni
system
found
aminotermin
region
metypcp
contain
put
methyltransferas
met
papainlik
cystein
proteas
pcp
function
domain
inhibit
ifnstimul
respons
element
isr
promot
activ
express
sever
ifnstimul
gene
isg
respons
ifni
show
metypcp
domain
interf
janu
kinas
jak
signal
transduc
activ
transcript
protein
stat
signal
pathway
inhibit
nuclear
transloc
phosphoryl
ifni
treatment
contrast
metypcp
effect
phosphoryl
limit
impact
activ
jakstat
pathway
ifnii
stimul
inhibitori
function
seem
genotypedepend
metypcp
signific
effect
jakstat
pathway
overal
studi
provid
evid
predict
metypcp
domain
hev
antagonis
activ
modul
ifn
respons
virus
read
frame
code
nonstructur
polyprotein
compos
sever
put
function
domain
includ
methyltransferas
met
domain
unknown
function
papainlik
cystein
proteas
pcp
macrodomain
x
helicas
rnadepend
rna
polymeras
rdrp
still
unclear
whether
express
singl
polyprotein
cleav
sever
function
protein
context
infect
multipl
studi
suggest
cleav
sever
product
wherea
other
report
lack
process
viral
polyprotein
use
differ
express
system
may
explain
conflict
result
recent
paper
suggest
cleav
thrombin
factor
xa
code
capsid
protein
multifunct
phosphoprotein
respect
four
genotyp
infect
human
genotyp
transmit
via
faecalor
rout
consumpt
contamin
water
soil
food
endem
region
contrast
genotyp
detect
human
anim
speci
worldwid
transmit
via
direct
contact
infect
anim
consumpt
infect
meat
human
case
hev
infect
caus
acut
hepat
selflimit
howev
fulmin
hepat
failur
occur
pregnant
women
endem
region
patient
underli
chronic
liver
diseas
elderli
recent
chronic
case
hepat
e
report
immunocompromis
patient
extrahepat
manifest
includ
renal
pancreat
neurolog
disord
link
hev
infect
except
china
countri
yet
commerci
hev
vaccin
treatment
hev
infect
approv
interferon
ifn
group
secret
cytokin
play
key
role
host
earli
antivir
respons
type
ifn
ifni
compos
mainli
produc
directli
respons
viral
infect
upon
sens
viral
molecular
signatur
special
cellular
receptor
retinoicacidinduc
gene
rig
ilik
receptor
rlr
tolllik
receptor
tlr
ifni
subsequ
bind
receptor
ifnar
cell
surfac
activ
janu
kinas
jak
signal
transduc
activ
transcript
protein
stat
signal
pathway
autocrin
paracrin
manner
bind
ifni
receptor
lead
phosphoryl
tyrosin
kinas
subsequ
phosphoryl
cytoplasm
domain
ifnar
subunit
recruit
phosphoryl
jak
kinas
tyrosin
tyrosin
respect
phosphoryl
heterodim
releas
cytoplasm
interact
ifn
respons
factor
form
ifnstimul
gene
isg
factor
transcript
factor
transloc
nucleu
bind
specif
promot
element
call
ifnstimul
respons
element
isr
lead
upregul
hundr
ifnstimul
gene
isg
may
display
antivir
properti
contribut
establish
rapid
robust
antivir
state
within
cell
cell
produc
ifni
contrast
type
ii
ifn
secret
mainli
activ
cell
natur
killer
cell
bind
cytokin
specif
receptor
ifngr
lead
phosphoryl
subsequ
phosphoryl
homodim
form
transloc
nucleu
bind
specif
promot
activ
transcript
differ
subset
isg
differ
report
suggest
ifn
respons
trigger
hev
express
ifni
multipl
isg
detect
infect
vivo
vitro
howev
ifni
seem
moder
delay
antivir
effect
hev
infect
vitro
patient
comparison
instanc
potent
effect
exert
hepat
c
viru
hcv
anoth
hepatotrop
rna
viru
consist
recent
studi
indic
host
isg
respons
ifni
inhibit
hev
infect
mechan
involv
inhibit
remain
poorli
character
nonstructur
polyprotein
hev
contain
one
sever
function
domain
abl
modul
ifni
system
macrodomain
pcp
domain
met
domain
describ
antagonist
signal
cascad
lead
ifn
synthesi
howev
noth
known
abil
viral
polyprotein
inhibit
respons
ifni
hepat
e
viru
hev
singlestrand
posit
rna
viru
belong
orthohepeviru
genu
within
hepevirida
famili
genom
kb
length
code
three
open
jakstat
pathway
address
question
studi
effect
hev
sever
domain
signal
pathway
use
transfect
cell
model
express
fulllength
fragment
fuse
flag
tag
difficult
detect
polyprotein
put
cleavag
product
context
infect
replic
particularli
interest
test
pcp
macrodomain
x
function
domain
encod
sever
rnaposit
virus
shown
modul
host
innat
immun
respons
aminotermin
end
metypcp
contain
met
pcp
also
includ
studi
put
zinc
finger
domain
present
met
might
critic
enzymat
activ
pcp
found
metypcp
domain
inhibit
isr
promot
activ
express
sever
isg
stimul
ifni
investig
reveal
metypcp
interf
nuclear
transloc
phosphoryl
overal
data
provid
evid
predict
metypcp
domain
hev
antagonis
activ
modul
ifn
respons
human
embryon
kidney
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
calf
serum
fc
pyruv
iuml
penicillin
streptomycin
ps
cell
maintain
c
airco
serum
french
patient
suffer
sever
hepat
e
provid
former
nation
refer
centr
hev
hia
val
de
pari
franc
strain
extract
sampl
use
qiamp
viral
rna
kit
qiagen
hilden
germani
revers
transcriptionpcr
rtpcr
perform
primescript
revers
transcriptas
takara
bio
inc
shiga
japan
total
seven
overlap
fragment
amplifi
use
hot
start
highfidel
phusion
polymeras
finnzym
thermo
fisher
scientif
waltham
usa
race
race
kit
invitrogen
thermo
fisher
scientif
waltham
usa
clone
plasmid
overlap
fragment
digest
restrict
enzym
ligat
dna
ligas
takara
bio
inc
shiga
japan
gener
dna
fragment
correspond
fulllength
viral
genom
downstream
promot
uniqu
swai
restrict
site
fragment
subsequ
clone
vector
gener
complet
nucleotid
sequenc
code
determin
sequenc
deposit
genbank
databas
access
number
posit
differ
put
function
domain
identifi
comparison
previou
computerbas
analysi
dna
sequenc
code
fulllength
well
metypcp
pcp
x
met
meti
ypcp
figur
amplifi
use
templat
specif
primer
tabl
standard
pcr
use
phusion
highfidel
dna
polymeras
thermo
fisher
scientif
waltham
usa
pcr
product
clone
vitro
recombin
gateway
system
invitrogen
thermo
fisher
scientif
waltham
usa
describ
previous
code
sequenc
subsequ
recombin
translationoptim
express
vector
use
gateway
clone
procedur
invitrogen
thermo
fisher
scientif
waltham
usa
similar
strategi
use
construct
plasmid
code
metypcp
pcp
rna
strain
extract
stool
sampl
patient
acut
hepat
provid
previou
nation
refer
centr
hev
hia
val
de
pari
franc
use
rneasi
kit
qiagen
hilden
germani
revers
transcript
perform
primescript
revers
transcriptas
takara
bio
inc
shiga
japan
accord
manufactur
protocol
three
overlap
fragment
cover
region
amplifi
use
ex
taq
polymeras
takara
bio
inc
shiga
japan
insert
topo
use
topo
ta
clone
kit
invitrogen
thermo
fisher
scientif
waltham
usa
construct
sequenc
use
templat
amplifi
sequenc
code
metypcp
pcp
specif
primer
tabl
express
vector
code
flagtag
metypcp
pcp
gener
use
gateway
clone
procedur
invitrogen
thermo
fisher
scientif
waltham
usa
describ
nucleotid
sequenc
strain
deposit
genbank
databas
access
number
amino
acid
sequenc
metypcp
pcp
fragment
strain
ident
strain
plasmid
code
v
protein
schwarz
strain
measl
viru
mv
fuse
tag
describ
previous
recombin
human
purchas
pbl
interferon
sourc
piscataway
nj
usa
recombin
human
peprotech
rocki
hill
nj
usa
mous
antiactin
monoclon
antibodi
clone
mous
antiflag
clone
sigmaaldrich
saintloui
mo
usa
polyclon
antibodi
tyr
merck
millipor
darmstadt
germani
rabbit
polyclon
antibodi
santacruz
biotechnolog
dalla
tx
usa
cell
transfect
plasmid
dna
use
jetprim
polyplu
transfect
strasbourg
franc
accord
manufactur
instruct
cell
seed
plate
cellswel
transfect
one
day
later
differ
construct
forti
hour
posttransfect
cell
lyse
cell
viabil
determin
use
celltiterglo
luminesc
cell
viabil
assay
promega
madison
wi
usa
accord
manufactur
recommend
assay
base
atp
quantif
indic
metabol
activ
cell
cell
plate
plate
cellswel
transfect
differ
construct
cell
lyse
radioimmunoprecipit
assay
ripa
buffer
mm
tri
hcl
ph
mm
nacl
nonidet
sodium
dodecyl
sulphat
supplement
cocktail
proteas
phosphatas
inhibitor
previous
describ
insolubl
materi
centrifug
g
min
c
discard
total
protein
concentr
solubl
fraction
determin
micro
bca
tm
protein
assay
pierc
thermo
fisher
scientif
waltham
usa
equal
amount
protein
extract
reduc
heat
presenc
resolv
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
follow
transfer
nitrocellulos
membran
hybondecl
amersham
ge
healthcar
lifesci
pittsburgh
pa
usa
membran
block
phosphatebuff
salin
pb
contain
dri
milk
membran
incub
requir
dilut
specif
antibodi
bound
primari
antibodi
detect
use
horseradish
peroxidaseconjug
antirabbit
antimous
secondari
antibodi
pierc
thermo
fisher
scientif
waltham
usa
enhanc
luminolbas
chemiluminesc
detect
system
band
intens
measur
scan
immunoblot
imag
use
imagej
softwar
cell
cellswel
seed
plate
twentyfour
hour
later
cell
transfect
ng
firefli
luciferas
isr
report
plasmid
contain
isr
enhanc
element
upstream
firefli
luciferas
gene
pisreluc
clontech
mountain
view
ca
usa
ng
report
plasmid
pcmvluc
contain
renilla
luciferas
gene
control
cytomegaloviru
cmv
promot
normal
data
ng
plasmid
code
domain
interest
fuse
tag
aminotermin
end
ng
empti
vector
neg
control
ng
plasmid
code
v
protein
measl
viru
mvv
fuse
tag
posit
control
forti
hour
later
supernat
remov
replac
fresh
complet
medium
contain
iuml
seven
hour
later
cell
lyse
passiv
lysi
buffer
promega
madison
wi
usa
firefli
renilla
luciferas
activ
determin
use
luciferas
assay
system
promega
madison
wi
usa
luciferas
assay
system
promega
madison
wi
usa
respect
normal
luciferas
activ
calcul
sampl
divid
firefli
luciferas
activ
renilla
luciferas
activ
cell
plate
plate
cellswel
transfect
empti
vector
plasmid
code
metypcp
pcp
mvv
fuse
tag
forti
hour
posttransfect
cell
stimul
h
iuml
total
rna
extract
use
rneasi
minikit
qiagen
hilden
germani
includ
digest
step
column
dnase
qiagen
hilden
germani
second
digest
step
perform
use
turbo
dnase
ambion
thermo
fisher
scientif
waltham
usa
rna
clean
column
use
rneasi
minikit
qiagen
hilden
germani
rt
done
use
ng
rna
primescript
revers
transcriptas
takara
bio
inc
shiga
japan
accord
manufactur
instruct
rtqpcr
perform
cdna
use
sybr
green
master
mix
kit
roch
basel
switzerland
specif
primer
tabl
lightcycl
apparatu
roch
basel
switzerland
use
sampl
analysi
sampl
denatur
min
c
dna
amplifi
cycl
c
c
c
final
extens
follow
cool
c
rel
quantif
realiz
use
method
glyceraldehyd
dehydrogenas
gapdh
use
endogen
control
normal
mean
obtain
nonstimul
cell
transfect
empti
vector
use
calibr
cell
cellswel
seed
onto
coverslip
previous
coat
polydlysin
sigmaaldrich
saintloui
mo
usa
plate
transfect
ng
empti
vector
ev
plasmid
code
metypcp
pcp
x
mvv
fuse
tag
twentyfour
hour
later
cell
treat
min
wash
pb
fix
paraformaldehyd
pb
cell
permeabilis
triton
pb
incub
block
buffer
bsa
pb
appropri
dilut
primari
antibodi
ad
h
room
temperatur
cell
wash
sever
time
pb
dylight
tm
antimous
dylight
tm
antirabbit
secondari
antibodi
thermo
scientif
thermo
fisher
scientif
waltham
usa
use
detect
bound
primari
antibodi
sampl
mount
mowiol
contain
dihydrochlorid
dapi
sigmaaldrich
saintloui
mo
usa
microscopi
carri
axio
observ
fluoresc
microscop
zeiss
oberkochen
germani
imag
acquir
use
zen
softwar
unpair
ttest
unequ
varianc
ttest
use
analys
data
differ
consid
signific
p
valu
sequenc
code
fulllength
metypcp
pcp
x
domain
strain
identifi
accord
previou
computerbas
analysi
amplifi
insert
express
vector
downstream
frame
sequenc
code
tag
figur
express
differ
construct
confirm
cell
immunoblot
figur
human
embryon
kidney
cell
use
give
high
transfect
effici
reach
hepat
cell
line
band
correspond
expect
molecular
weight
kda
flagi
kda
flagx
kda
flagmetypcp
kda
detect
band
lower
molecular
weight
also
observ
flagmetypcp
suggest
cleavag
degrad
protein
contrast
band
correspond
higher
molecular
weight
one
expect
kda
detect
flagpcp
suggest
posttransl
modif
dimer
viral
protein
figur
assess
abil
differ
hev
product
interfer
ifni
respons
first
examin
effect
isr
promot
activ
use
luciferas
report
assay
cell
transfect
isrereport
plasmid
pisreluc
control
vector
pcmvluc
normal
transfect
empti
vector
plasmid
code
metypcp
pcp
x
cell
treat
h
later
h
posit
control
cell
transfect
plasmid
code
v
protein
schwarz
strain
measl
viru
mvv
fuse
flag
tag
aminotermin
viral
protein
inhibit
ifni
respons
interact
interf
phosphoryl
shown
figur
supplementari
materi
tabl
express
metypcp
abl
inhibit
significantli
isr
promot
activ
stimul
inhibit
due
cytotox
effect
viral
protein
transfect
construct
code
metypcp
h
affect
cell
viabil
figur
metypcp
inhibitori
effect
isr
promot
modest
compar
one
mvv
might
due
low
express
level
metypcp
report
assay
supplementari
materi
figur
contrast
signific
inhibit
detect
pcp
alon
express
interest
note
metypcp
pcp
abl
inhibit
significantli
promot
activ
stimul
rlr
pathway
luciferas
report
assay
result
agreement
previou
find
show
pcp
inhibitor
rlr
pathway
suggest
pcp
domain
express
studi
function
impact
isr
promot
activ
assay
rel
low
express
fulllength
lack
process
polyprotein
cell
figur
supplementari
materi
figur
might
mask
put
inhibitori
effect
determin
whether
entir
metypcp
product
necessari
inhibit
isr
promot
activ
also
test
effect
met
meti
ypcp
hev
isr
promot
activ
use
luciferas
report
assay
figur
c
supplementari
materi
figur
tabl
shown
figur
express
met
alon
result
signific
increas
isr
promot
activ
meti
ypcp
effect
isr
promot
activ
result
suggest
express
aminotermin
region
contain
met
pcp
domain
necessari
inhibit
signal
pathway
trigger
ifni
focuss
metypcp
confirm
antagonist
effect
ifni
respons
examin
level
induct
isg
mrna
treatment
rtqpcr
upon
metypcp
express
figur
supplementari
materi
figur
also
includ
assay
mvv
posit
control
pcp
addit
neg
control
domain
effect
isr
promot
activ
figur
cell
transfect
empti
vector
plasmid
code
mvv
pcp
metypcp
h
stimul
h
found
follow
treatment
express
metypcp
abl
significantli
downregul
mrna
level
figur
melanoma
differentiationassoci
protein
figur
oligoadenyl
synthetas
figur
result
confirm
previou
observ
figur
metypcp
pcp
alon
abl
counteract
ifni
respons
virus
x
peer
review
assay
mvv
posit
control
pcp
addit
neg
control
domain
effect
isr
promot
activ
figur
cell
transfect
empti
vector
plasmid
code
mvv
pcp
metypcp
h
stimul
h
found
follow
treatment
express
metypcp
abl
significantli
downregul
mrna
level
figur
melanoma
differentiationassoci
protein
figur
synthetas
figur
result
confirm
previou
observ
figur
metypcp
pcp
alon
abl
counteract
ifni
respons
better
understand
mechan
involv
inhibit
ifni
respons
metypcp
examin
whether
viral
protein
abl
interfer
jakstat
pathway
first
assess
abil
metypcp
modul
nuclear
transloc
stimul
immunofluoresc
absenc
ifn
treatment
found
predominantli
cytoplasm
cell
transfect
empti
vector
plasmid
code
flagtag
metypcp
pcp
mvv
figur
upper
panel
also
found
nucleu
transcript
factor
shuttl
nucleu
cytoplasm
unstimul
cell
treatment
led
nuclear
accumul
cell
transfect
empti
vector
plasmid
code
pcp
figur
lower
panel
contrast
remain
diffus
cytoplasm
nucleu
proport
cell
express
metypcp
mvv
figur
lower
panel
quantifi
number
cell
show
predomin
nuclear
localis
number
cell
cytoplasmicnuclear
localis
upon
stimul
figur
signific
decreas
percentag
cell
show
nuclear
localis
found
cell
express
metypcp
mvv
comparison
cell
transfect
empti
plasmid
express
pcp
thu
suggest
metypcp
interf
nuclear
transloc
addit
met
x
effect
nuclear
transloc
supplementari
materi
figur
thu
corrobor
result
report
assay
figur
interestingli
metypcp
localis
frequent
dens
structur
around
nucleu
upon
stimul
possibl
viral
protein
interact
cellular
protein
whose
express
induc
lead
chang
localis
upon
stimul
differ
localis
also
observ
pcp
less
appar
metypcp
green
red
visual
microscopi
magnif
scale
bar
cell
show
diffus
cytoplasmicnuclear
localis
upon
treatment
indic
arrow
b
local
visual
immunostain
describ
cell
transfect
empti
vector
plasmid
code
metypcp
pcp
mvv
fuse
flag
tag
condit
localis
predomin
nuclear
localis
diffus
localis
within
cytoplasm
nucleu
determin
cell
express
correspond
flagtag
protein
except
ev
control
cell
randomli
assess
mean
percentag
standard
deviat
cell
show
predomin
nuclear
local
three
independ
experi
shown
p
p
compar
ev
control
treat
sampl
unpair
ttest
investig
step
jakstat
pathway
target
metypcp
assess
phosphoryl
statu
treatment
immunoblot
analysi
cell
express
metypcp
pcp
cell
express
mvv
use
posit
control
shown
figur
b
level
phosphoryl
detect
treatment
reduc
significantli
cell
express
metypcp
comparison
cell
transfect
empti
vector
express
pcp
chang
total
level
observ
cell
express
metypcp
indic
viral
protein
interfer
express
stabil
moreov
also
assess
phosphoryl
statu
found
metypcp
signific
effect
level
total
phosphoryl
figur
c
suggest
metypcp
interf
activ
follow
ifni
treatment
virus
x
peer
review
cell
transfect
empti
vector
plasmid
code
metypcp
pcp
mvv
treat
describ
cell
lysat
extract
use
detect
total
actin
immunoblot
band
intens
quantifi
use
imagej
softwar
rel
level
actin
determin
treat
sampl
ratio
actin
actin
calcul
express
rel
percentag
comparison
ev
control
c
cell
transfect
empti
vector
plasmid
code
metypcp
mvv
treat
describ
cell
lysat
extract
use
detect
total
immunoblot
band
intens
quantifi
use
imagej
softwar
rel
level
actin
determin
treat
sampl
ratio
actin
actin
calcul
express
rel
percentag
comparison
ev
control
ratio
actin
also
determin
ensur
signific
inhibit
level
metypcp
set
experi
bc
mean
percentag
standard
deviat
four
independ
experi
present
panel
p
cell
lysat
extract
use
detect
total
actin
immunoblot
band
intens
quantifi
use
imagej
softwar
rel
level
actin
determin
treat
sampl
ratio
actin
actin
calcul
express
rel
percentag
comparison
ev
control
c
cell
transfect
empti
vector
plasmid
code
metypcp
mvv
treat
describ
cell
lysat
extract
use
detect
total
immunoblot
band
intens
quantifi
use
imagej
softwar
rel
level
actin
determin
treat
sampl
ratio
actin
actin
calcul
express
rel
percentag
comparison
ev
control
ratio
actin
also
determin
ensur
signific
inhibit
level
metypcp
set
experi
bc
mean
percentag
standard
deviat
four
independ
experi
present
panel
p
p
p
compar
ev
control
ifntreat
sampl
unequ
varianc
ttest
want
determin
whether
metypcp
abil
inhibit
jakstat
pathway
respons
ifnii
ifni
ii
activ
trigger
differ
compon
jakstat
pathway
experi
could
help
pinpoint
level
pathway
metypcp
act
first
assess
effect
metypcp
express
nuclear
transloc
stimul
immunofluoresc
figur
supplementari
materi
figur
treatment
led
nuclear
transloc
around
cell
transfect
empti
vector
around
cell
express
metypcp
figur
thu
suggest
metypcp
abl
inhibit
transloc
respons
howev
antagonist
effect
less
pronounc
one
observ
treatment
cell
express
metypcp
display
predomin
local
nucleu
figur
also
assess
abil
metypcp
inhibit
phosphoryl
ifnii
treatment
cell
express
metypcp
treat
min
level
phosphoryl
quantifi
immunoblot
shown
figur
c
signific
inhibit
phosphoryl
detect
cell
express
metypcp
follow
treatment
result
suggest
metypcp
limit
impact
jakstat
pathway
ifnii
treatment
similarli
metypcp
mvv
caus
slight
decreas
transloc
figur
inhibit
phosphoryl
figur
c
treatment
result
agreement
sever
studi
show
mvv
effici
antagon
respons
ifni
comparison
ifnii
figur
express
metypcp
hev
inhibit
weakli
transloc
phosphoryl
respons
ifnii
cell
transfect
empti
vector
plasmid
code
metypcp
mvv
fuse
tag
twentyfour
hour
posttransfect
cell
stimul
min
iuml
ngml
cell
wash
fix
stain
primari
antibodi
rais
flag
follow
fluoresc
dyeconjug
secondari
antibodi
local
determin
cell
express
correspond
flagtag
protein
except
ev
control
cell
randomli
assess
mean
percentag
standard
deviat
cell
show
predomin
nuclear
local
three
independ
experi
shown
p
p
p
compar
ev
control
treat
sampl
unpair
ttest
b
cell
transfect
empti
vector
plasmid
code
metypcp
pcp
mvv
fuse
tag
twentyfour
hour
posttransfect
cell
figur
express
metypcp
hev
inhibit
weakli
transloc
phosphoryl
respons
ifnii
cell
transfect
empti
vector
plasmid
code
metypcp
mvv
fuse
tag
twentyfour
hour
posttransfect
cell
stimul
min
iuml
ngml
cell
wash
fix
stain
primari
antibodi
rais
flag
follow
fluoresc
dyeconjug
secondari
antibodi
local
determin
cell
express
correspond
flagtag
protein
except
ev
control
cell
randomli
assess
mean
percentag
standard
deviat
cell
show
predomin
nuclear
local
three
independ
experi
shown
p
p
p
compar
ev
control
treat
sampl
unpair
ttest
b
cell
transfect
empti
vector
plasmid
code
metypcp
pcp
mvv
fuse
tag
twentyfour
hour
posttransfect
cell
stimul
min
iuml
ngml
cell
lysat
extract
use
detect
flagtag
protein
total
phosphoryl
actin
intern
control
immunoblot
c
band
intens
quantifi
use
imagej
softwar
rel
level
actin
determin
sampl
treat
ngml
iuml
ratio
actin
actin
calcul
express
rel
percentag
comparison
ev
control
mean
percentag
standard
deviat
three
independ
experi
present
p
compar
ev
control
unequ
varianc
ttest
wonder
whether
abil
metypcp
inhibit
jakstat
pathway
genotypespecif
differ
human
zoonot
genotyp
achiev
sequenc
code
metypcp
pcp
domain
strain
clone
insert
express
vector
found
amino
acid
sequenc
ident
metypcp
domain
strain
clone
studi
supplementari
materi
figur
pcp
domain
express
fragment
confirm
cell
immunoblot
figur
effect
metypcp
pcp
domain
isr
promot
activ
assess
use
luciferas
report
assay
describ
shown
figur
supplementari
materi
tabl
metypcp
abl
inhibit
isr
promot
activ
treatment
differ
due
problem
express
metypcp
domain
effici
express
cell
metypcp
impact
cell
viabil
figur
supplementari
materi
figur
agreement
result
also
found
express
metypcp
inhibit
significantli
nuclear
transloc
stimul
figur
supplementari
materi
figur
altogeth
result
suggest
metypcp
domain
abl
inhibit
jakstat
pathway
effici
one
differ
abil
metypcp
interfer
jakstat
pathway
exist
hev
genotyp
virus
encod
multifunct
viral
protein
counteract
host
antivir
respons
sever
level
ifn
induct
signal
pathway
recent
studi
report
pcp
domain
macrodomain
met
domain
hev
antagonist
ifn
induct
macrodomain
shown
interfer
phosphoryl
wherea
pcp
abl
deubiquitin
compon
rlr
pathway
rigi
tank
bind
kinas
cell
show
aminotermin
region
hev
abl
inhibit
ifni
respons
target
jakstat
pathway
thu
domain
nonstructur
polyprotein
counteract
host
ifn
system
level
ifn
induct
ifn
signal
studi
studi
overexpress
tag
version
sever
domain
cell
studi
potenti
inhibitori
function
ifni
respons
strategi
allow
us
overcom
difficulti
encount
effici
infect
cell
vitro
hev
detect
protein
express
futur
studi
import
valid
effect
metypcp
jakstat
pathway
hepatocyt
main
target
viru
nevertheless
sever
studi
suggest
hev
replic
kidney
hev
rna
andor
antigen
detect
kidney
tissu
hevinfect
gerbil
monkey
swine
rabbit
embryon
kidney
cell
cell
thu
repres
relev
model
studi
hev
found
protein
encompass
predict
met
pcp
domain
hev
inhibit
isr
promot
activ
express
sever
isg
respons
investig
reveal
metypcp
interf
nuclear
transloc
phosphoryl
thu
indic
metypcp
target
jakstat
pathway
moreov
metypcp
seem
act
specif
activ
phosphoryl
affect
express
product
key
compon
jakstat
pathway
target
larg
number
viral
protein
multipl
mechan
inhibit
describ
viral
protein
interact
directli
block
phosphoryl
other
act
phosphatas
dephosphoryl
sequest
cytoplasm
induc
degrad
found
metypcp
affect
total
level
suggest
metypcp
abl
degrad
cellular
protein
affect
express
howev
found
metypcp
abl
inhibit
phosphoryl
effici
respons
thu
suggest
metypcp
interf
specif
one
sever
compon
regul
jakstat
pathway
trigger
ifni
activ
jakstat
pathway
type
ii
ifn
involv
specif
receptor
ifngr
phosphoryl
activ
ifni
one
hypothes
metypcp
interfer
recruit
ifnar
subunit
phosphoryl
metypcp
could
also
interfer
cellular
protein
involv
regul
ifnidriven
phosphoryl
addit
possibl
metypcp
target
sever
step
jakstat
pathway
one
target
upstream
phosphoryl
specif
ifni
respons
anoth
upstream
transloc
common
ifni
ii
respons
would
explain
found
metypcp
inhibit
significantli
transloc
phosphoryl
ifnii
treatment
also
found
product
contain
predict
function
met
pcp
domain
abl
inhibit
isr
promot
activ
met
pcp
alon
combin
met
pcp
surprisingli
contrast
metypcp
express
met
significantli
enhanc
isr
promot
activ
investig
mechan
involv
stimulatori
effect
function
met
might
differ
depend
whether
express
alon
coexpress
domain
one
region
metypcp
might
need
localis
catalyt
activ
anoth
interact
specif
cellular
protein
previou
studi
report
put
zincfing
domain
present
met
amino
acid
might
critic
enzymat
activ
pcp
mani
viral
cystein
proteas
requir
zincbind
finger
motif
catalyt
activ
function
antagonist
ifn
respons
exampl
zincfing
domain
porcin
reproduct
respiratori
syndrom
viru
prrsv
critic
viral
protein
inhibit
synthesi
one
envisag
enzymat
activ
hev
pcp
depend
zincfing
domain
present
met
import
inhibitori
action
metypcp
would
explain
metypcp
abl
inhibit
jakstat
pathway
pcp
alon
less
effici
futur
work
would
interest
assess
inhibitori
effect
metypcp
mutant
disrupt
zincbind
finger
motif
check
hypothesi
result
show
abil
metypcp
inhibit
jakstat
pathway
differ
accord
hev
genotyp
involv
result
need
investig
differ
could
explain
least
partial
distinct
pathogenesi
speci
tropism
observ
human
zoonot
genotyp
amino
acid
sequenc
metypcp
genotyp
ident
metypcp
genotyp
supplementari
materi
figur
main
differ
amino
acid
sequenc
two
genotyp
present
ctermin
part
amino
acid
correspond
pcp
domain
would
interest
construct
metypcp
chimera
carri
meti
domain
pcp
domain
vice
versa
determin
part
metypcp
respons
inhibitori
function
jakstat
pathway
addit
recent
paper
suggest
factor
xa
cleavag
site
present
amino
acid
within
pcp
domain
strain
present
strain
differ
process
genotyp
could
affect
function
ifni
antagonist
need
better
characteris
recent
studi
undertaken
understand
hev
interact
immun
system
host
data
studi
expand
knowledg
mechan
evolv
hev
counteract
ifn
respons
provid
addit
evid
play
multipl
role
evas
strategi
better
understand
signal
pathway
target
hev
protein
modul
host
antivir
respons
help
identifi
new
therapeut
target
improv
prevent
control
hev
infect
critic
antihev
drug
approv
yet
particularli
relev
treatment
chronic
case
hepat
e
immunosuppress
patient
follow
avail
onlin
http
tabl
raw
data
luciferas
report
assay
present
figur
tabl
raw
data
luciferas
report
assay
present
figur
figur
express
flagtag
fulllength
domain
cotransfect
cell
figur
rel
express
mrna
determin
rtqpcr
independ
experi
present
figur
figur
express
x
met
hev
impact
nuclear
transloc
upon
treatment
figur
effect
metypcp
hev
transloc
respons
ifnii
figur
align
amino
acid
sequenc
metypcp
genotyp
figur
express
flagtag
metypcp
pcp
genotyp
cotransfect
cell
figur
cell
viabil
assay
cell
express
metypcp
pcp
figur
effect
metypcp
transloc
